U.S. Markets open in 3 hrs 44 mins

U.S. judge rules for Sanofi in Amgen patent fight

Aug 28 (Reuters) - A U.S. judge on Wendesday largely set aside a jury verdict that Amgen Inc patents on its cholesterol drug Repatha were valid, handing a victory to Regeneron Pharmaceuticals Inc and Sanofi SA. (Reporting by Jan Wolfe; editing by Jonathan Oatis)